DelveInsight’s Iron Overload Syndrome Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. 

The Iron Overload Syndrome market report also offers comprehensive insights into the Iron Overload Syndrome market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing iron overload syndrome market size growth forward. 

Iron Overload Syndrome Market Insights

Some of the key highlights from the Iron Overload Syndrome Market Insights:

  • According to Crooks et al. (2008), the total hemochromatosis prevalence in the United Kingdom increased by two-fold throughout the decade, from 3.62 to 7.8 per 100 000 people. The age range 40–69 was the most common, accounting for 64 percent of all hemochromatosis cases.
  • Major players such as Protagonist Therapeutics, Inc., AbFero Pharmaceuticals, Novartis Pharmaceuticals, and others are developing therapies for the treatment and management of Iron overload syndrome. These therapies are currently under different stages of development. 
  • Key pipeline therapies in the Iron overload syndrome market include PTG-300, SP-420, Exjade, among others.

Learn more by requesting for sample @ Iron Overload Syndrome Market Landscape 

Iron Overload Syndrome: Overview 

Iron is required for cell metabolism and the production of hemoglobin, myoglobin, and cytochrome P450, among other hemoproteins. As a result, under normal physiologic settings, total body iron levels are carefully regulated. Iron overload can be inherited (genetic) or acquired through many blood transfusions, iron shots or injections, or additional iron consumption.

Hereditary hemochromatosis (all types), African iron overload, sickle cell disease, thalassemia, X-linked sideroblastic anemia, enzyme deficiencies (pyruvate kinase; glucose-6-phosphate dehydrogenase), and sporadic protein transport disorders aceruloplasminemia and atransferrinemia are some of the genetic disorders that cause iron overload syndrome.

For more insights into disease, causes, and treatment, reach out to Iron Overload Syndrome Treatment Landscape

Iron Overload Syndrome Epidemiology Segmentation 

The Iron Overload Syndrome Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Iron Overload Syndrome Prevalence 
  • Age-Specific Iron Overload Syndrome Prevalence 
  • Gender-Specific Iron Overload Syndrome Prevalence 
  • Diagnosed and Treatable Cases of Iron Overload Syndrome

Visit for more @ Iron Overload Syndrome Epidemiological Insights

Iron Overload Syndrome Market 

An increase in the number of cases of iron overload syndrome, along with the expected approval of emerging therapies will boost the iron overload syndrome market in the forecasted period [2021-2030]. The iron overload syndrome pipeline brings a positive ray of hope for a better treatment pattern in the market in the upcoming years. The current scenario also anticipates a positive shift in the market.

PTG-300 is the most anticipated emerging therapy that is awaiting approval. Another treatment, Exjade (Deferasirox), is being evaluated in a phase II trial in patients with HH, which was previously approved to treat chronic iron overload due to blood transfusions.

Iron Overload Syndrome Pipeline Therapies and Key Companies 

  • PTG-300: Protagonist Therapeutics, Inc.
  • SP-420: AbFero Pharmaceuticals
  • Exjade: Novartis Pharmaceuticals

For more information, visit Iron Overload Syndrome Market Analysis, Patient Pool, and Emerging Therapies

Iron Overload Syndrome Market Drivers 

  • Rising prevalent population
  • Technological advancements
  • Emerging therapies 
  • Extensive R&D

Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Iron Overload Syndrome, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
  • Comprehensive insight into Iron Overload Syndrome epidemiology and treatment in the 7MM
  • Iron Overload Syndrome current and emerging therapies 
  • Iron Overload Syndrome market drivers and barriers 

Key Questions Answered in the Report:

  • What was the Iron Overload Syndrome market share (percentage) distribution in 2017, and how would it appear in 2030?
  • What is the total Iron overload syndrome market size and the market size by therapy across the 7MM for the projected period (2017-2030)?
  • What are the important findings from 7MM, and which country will have the greatest Iron Overload Syndrome market size from 2017 to 2030?
  • During the projection period (2017-2030), at what CAGR is the Iron Overload Syndrome market projected to expand at 7MM?

Get in touch with our Business executive @ Iron Overload Syndrome Market Landscape Analysis

Table of Contents:

1. Key Insights
2. Report Introduction
3. Competitive Intelligence Analysis for Iron Overload Syndrome
4. Iron Overload Syndrome Market Overview at a Glance
5. Executive Summary of Iron Overload Syndrome
6. Iron Overload Syndrome Epidemiology and Market Methodology
7. Iron Overload Syndrome Epidemiology and Patient Population
8. Iron Overload Syndrome Patient Journey
9. Treatment Algorithm, Current Treatment, and Medical Practices
10. Key Endpoints in Iron Overload Syndrome Clinical Trials
11. Iron Overload Syndrome Marketed Therapies
12. Iron Overload Syndrome Emerging Therapies
13. Iron Overload Syndrome: 7 Major Market Analysis
14. Attribute analysis
15. Access and Reimbursement Overview of Iron Overload Syndrome
16. KOL Reviews
17. Case Reports
18. Iron Overload Syndrome Market Drivers
19. Iron Overload Syndrome Market Barriers
20. SWOT Analysis
21. Disclaimer
22. DelveInsight Capabilities
23. About DelveInsight

Learn more about the report offerings @ Iron Overload Syndrome Market Outlook

Related Reports:

Iron Overload Syndrome Epidemiology

DelveInsight’s ‘Iron Overload Syndrome – Epidemiology Forecast to 2030’ report.

Latest Reports:

Intrahepatic Cholangiocarcinoma (ICCA) Market

DelveInsight’s ‘Intrahepatic Cholangiocarcinoma (ICCA) – Market Insights, Epidemiology, and Market Forecast–2030’ report.

COVID 19 Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020

DelveInsight’s ‘COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020’ report.

Cervical Dysplasia Market

DelveInsight’s “Cervical Dysplasia – Market Insights, Epidemiology, and Market Forecast-2030” report.

Agoraphobia Market

DelveInsight’s “Agoraphobia – Market Insights, Epidemiology, and Market Forecast-2030” report.

Hydrocephalus Market

DelveInsight’s “Hydrocephalus – Market Insights, Epidemiology, and Market Forecast-2030” report.

Sarcopenia Market

DelveInsight’s ‘Sarcopenia–Market Insights, Epidemiology, and Market Forecast-2030’ report.

Diabetic Kidney Disease Market

DelveInsight’s “Diabetic Kidney Disease (DKD) – Market Insights, Epidemiology, and Market Forecast-2030” report.

Acromegaly Market

DelveInsight’s ‘Acromegaly-Market Insights, Epidemiology, and Market Forecast–2030’ report.

Acute Respiratory Distress Syndrome (ARDS) Market

DelveInsight’s ‘Acute Respiratory Distress Syndrome (ARDS) – Market Insights, Epidemiology and Market Forecast – 2030’ report.

Acute Kidney Injury (AKI) Market

DelveInsight’s ‘Acute Kidney Injury (AKI) – Market Insights, Epidemiology and Market Forecast– 2030’ report.

Renal Anemia Market

DelveInsight’s “Renal Anemia – Market Insights, Epidemiology, and Market Forecast-2030” report.

About DelveInsight 

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.  

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Tags: ironoverloadsyndromemarket, ironoverloadsyndromemarkettrends, ironoverloadsyndromemarketsize, ironoverloadsyndromemarketshare, ironoverloadsyndromeepidemiology, ironoverloadsyndromekeycompanies, ironoverloadsyndromepipelinetherapies, ironoverloadsyndrometherapies

Contact Information:

Kritika Rehani
[email protected]
+1(919)321-6187